In this presentation we will dscuss the imp imaging features of Posterior fossa tumors in pediatric age group.
Medulloblastoma
Pilocytic Astrocytoma
Ependymoma
Brainstem Glioma
Schwanoma
Meningioma
Epidermoid Cyst
Arachnoid Cyst
In this presentation we will dscuss the imp imaging features of Posterior fossa tumors in pediatric age group.
Medulloblastoma
Pilocytic Astrocytoma
Ependymoma
Brainstem Glioma
Schwanoma
Meningioma
Epidermoid Cyst
Arachnoid Cyst
leptomeningeal metastases, leptomeningeal carcinomatosis, clinical features of leptomeningeal metastases, pathophysiology of leptomeningeal metastases, diagnosis of leptomeningeal metastases, CSF analysis, MRI findings in leptomeningeal metastases, treatment of leptomeningeal metastases,
Evaluation of Lumbar Spine Disease starts with understanding the clinical back grounds. It starts with good history and physical examination. This is a teaching lecture given twice by Prof. Dr. Mohamed Mohi Eldin, professor of neurosurgery, in the Basic Spine Course, Egyptian Medical Syndicate, Cairo, March 2009 and in 2010.
Schmorl’s nodes (SN) or Intervertebral Disc Herniations are Commonly observed on routine radiographs at autopsy.
This is a teaching lecture given by Prof. Dr. Mohamed Mohi Eldin, professor of neurosurgery, in the weekly conference of kasr El Aini Neurosurgery Department, Cairo University, November 2010.
This is an informative, illustrated presentation about the causes, symptoms, treatment and prevention of HIV AIDS. Gives relevant data, facts and statistics about the disease updated to the most recent 2010 data.
Primary mediastinal liposarcoma of the superior, middle, and anterior mediast...Mary Ondinee Manalo Igot
Primary mediastinal liposarcoma of the superior, middle, and anterior mediastinum
https://www.actamedicaphilippina.org/issue/1102
Very beggining of my post graduation journey I prepared it for weekly presentation in my oncology department RAJSHAHI MEDICAL COLLEGE. sharing here if anyone get any help who r begginer in this field. Thank you.
Advancements in Cancer Research with Special Reference to Pathogenesis and Di...Rahul Kadam
Cancer is a major human and animal health problem worldwide and is the second leading cause of death in the world wide. Over the past 30 years .significant progress has been achieved in understanding the molecular basis of cancer. The accumulation of this basic knowledge has established that cancer is a variety of distinct disease and that defective gene cause this disease. Further gene defect are diverse in nature and can involve either loss or gain of gene function.
HEAD AND NECK OCCULT PRIMARY CANCERS. SAM & RICH.pptxRitchieShija
Carcinoma of unknown primary is a diagnosis given when doctors aren't able to locate where a cancer began.
Most often, cancer is diagnosed when doctors discover the spot where the cancer began (primary tumor). If the cancer has spread (metastasized), those sites might be discovered, too.
In carcinoma of unknown primary, also known as occult primary cancer, doctors find the cancer cells that spread in the body, but they can't find the primary tumor.
In carcinoma of unknown primary, also known as occult primary cancer, doctors find the cancer cells that spread in the body, but they can't find the primary tumor. Doctors consider the location of the primary tumor when choosing the most appropriate treatments.So if carcinoma of unknown primary is found, doctors work to try to identify the primary tumor site. Your doctor might consider your risk factors, symptoms, and results from exams, imaging tests and pathology tests when trying to determine where your cancer began.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
4. Leptomeninges – defined as the Pia mater
and the arachnoid.
Ability to metastasize from the primary
tumor and spread to distant sites in the
body is a cardinal feature of malignancy.
Invasion of leptomeninges or CSF by cancer
is called leptomeningeal metastasis (LM) or
neoplastic meningitis.
6. Historically, LM were often diagnosed at
autopsy.
1978 : Among 2375 autopsies of cancer pts,
LM occurred in 8%1
2008 : Metastasis to the brain parenchyma
is relatively common, occurring in 9% to 15%
of cases in autopsy studies of patients who
die of cancer,3 and tumors can also
metastasize to the dura or to the
leptomeninges.4
1-Postner, Intracranial metastanses from systemic cancer, Advances in Neurology 1978
3-DeAngelis L, Posner J. Neurological complications of cancer. 2nd ed. New York,NY: Oxford University Press, 2008
4-Suki D, Abouassi H, Patel AJ, et al. Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to
the posterior fossa. J Neurosurg 2008;108(2):248Y257
7. LM known for well over 100 years5; it was
once thought to be rare but has been
diagnosed more frequently in recent years.
3-DeAngelis L, Posner J. Neurological complications of cancer. 2nd ed. New York,NY: Oxford University Press, 2008
4-Suki D, Abouassi H, Patel AJ, et al. Comparative risk of leptomeningeal disease after resection or stereotactic
radiosurgery for solid tumor metastasis to the posterior fossa. J Neurosurg 2008;108(2):248Y257
5-Eberth C. Zur Entwickelung des Epithelioms (Cholesteatoms) der Pia und der Lunge. Virchows Arch 1870;49:51Y63
8. Multiple reasons for the increased
frequency of diagnosis of LM
› Improved diagnostic methods → MRI
› More frequency use of MRI
› Survive longer → more effective Tx, and
LM tends to be a late-stage development
› Use of agents that do not cross the blood
brain barrier eg, trastuzumab in breast
cancer and gefitinib or erlotinib in non-
small cell lung cancer
10. Clinically diagnosed LM affect ~ 5% of pt
with metastatic cancer but undiagnosed or
asymptomatic involvement is more
common2
In Autopsy studies → the frequency of LM
averages 19% of pts with cancer pts.6
LM is diagnosed in 7
› 4-15% of pt with solid tumors
› 5-15% of pt with leukemia and lymphoma
› 1-2% of pt with primary brain tumor
2-Marc C., The Neurologist 2006;12: 179–187
6-Glass JP, Melamed M, Chernik NL, et al. Malignant cells in cerebrospinalfluid (CSF): the meaning of a positive CSF cytology.
Neurology 1979;29:1369 –1375.
7-Chamberlain MC. Carcinomatous meningitis. Arch Neurol. 1997;54:16–17.
11. Adenocarcinoma is the most frequent
histology.2
Breast, lung and melanoma are the most
common primary sites to LM.2
>70% presents in pts with widely
disseminated and progressive systemic
cancer 2
20% present after a disease-free interval2
5-10% be the first manisfestation of
cancer2
2-Marc C., The Neurologist 2006;12: 179–187
13. Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):328–342.
14. Median age
› 56 yr (19-87 yr)
Median Karnofsky Performance Scale Score
› 70 (10-100)
Length of time from initial cancer Dx to Dx
of LM
› 0-22.6 yr
Median interval times
› Solid tumor 2 yr
› Hematologic primary tumor 11 months
2-Marc C., The Neurologist 2006;12: 179–187
15. Mortality/Morbidity8
› Median survival;
7 months for LM from Breast cancers
4 months for LM from Small cell lung cancers
3.6 months for LM from Melanomas
› Without therapy, survive 4-6 weeks (death
with progressive neurologic dysfunction)
› With therapy, most pts die from the systemic
complication of their cancer
8-R Andrew Sewell, Leptomeningeal Carcinomatosis , Medscape
16. Treatment remains palliative, and median
survival is typically in the range of 2 to 3
months.
In the MSKCC series
› Overall median survival was 2.4 months (95% CI,
1.9-3.1).
› Median survival for patients with solid tumors was
2.3 months (95% CI,1.7-2.6)
› Median survival for patients with hematopoietic
tumors was a slightly better 4.7 months
(95%CI, 2.7-6.8)
12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
17. 12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
19. Cancer cells reach the meninges by
various routes9
1. Direct extension from contiguous tumor
deposits
2. Hematogenous spread, either through the
venous plexus of Batson or by arterial
dissemination
3. Through centripetal migration from systemic
tumors along perineural or perivascular
spaces
9-Roelein h., Leptomeningeal metastases, Cancer treatment and research, Springer 2005
20. Tumor cells may also invade the spinal or
cranial nerves, cerebral cortex, or spinal
cord via the Virchow-Robin spaces
Cancer cells are transported by CSF flow
resulting in disseminated and multifocal
neuraxis seeding of LM
Tumor infiltration is most prominent at the
base of brain (basillar cisterns), the dorsal
surface of the spinal cord, and the cauda
equina
21. 12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
22. 12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
24. LM classically presents with pleomorphic
clinical manisfestations encompassing
synmptoms and signs in 3 domains
› Cerebral hemispheres
› Posterior fossa/Cranial nerves
› Spinal cord and roots
25. 12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
26. 12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
27. 12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
28. The finding of multifocal neuraxis disease in
a patient with known malignancy is strongly
suggestive of LM
1/3 patients with LM to present with isolated
syndromes such as symptoms of raised
intracranial pressure, cauda equina
syndrome, or cranial neuropathy.
30. The evaluation begins with a careful
history, seeking complaints suggestive of
multifocal involvement.
The diagnosis of LM is straightforward in
the patient with advanced cancer,
multifocal signs and symptoms, typical
imaging findings, and positive CSF
cytology.
Pathophysiology, clinical features, and diagnosis of leptomeningeal metastases (carcinomatous meningitis), Uptodate
31. MRI and CSF are complementary, and the use
of both increases diagnostic accuracy.10
An enhanced MRI of the symptomatic region
of brain or spine should be obtained prior to
doing a lumbar puncture (LP) or ventricular
tap.
A positive CSF cytology establishes the
diagnosis of LM.
10-Straathof CS, de Bruin HG, Dippel DW, Vecht CJ. The diagnostic accuracy of magnetic resonance imaging
and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 1999; 246:810.
32. Patients may be diagnosed with LM when
one of the following criteria is met:11
1. Positive CSF cytology
2. Positive LM biopsy
3. Positive MRI in a pateint with a clinical
syndrome compatible with the diagnosis
4. Abnormal CSF biochemical markers consistent
with LM
11-Roelein h., Leptomeningeal metastases, Cancer treatment and research, Springer 2005
33. MRI should be performed in pt with
suspected LM.
MRI with gadolinium enhancement(MR-Gd)
is the technique of choice to evaluate
patients with suspected leptomeningeal
metastasis.
T1-weighted sequences, with and without
contrast, combined with fat suppression T2-
weighted sequences, constitute the
standard examination.
34. Highly sensitive for diagnosis of LM from
solid tumors (76-100%)
Less sensitive for hematopoieric tumors
MSKCC
› 98% of solid tumor → MRI positive for LM 88%
› 88% of hematopoietic tumor → MRI positive
for LM 48%
35. Typical MRI findings
› Leptomeningeal enhancement in LM can be linear
but often has irrigularity or nodularity
› Often visible in the subarachnoid space, cerebellar
folia, or cortical surface, and tumor masses,
especially at the base of the brain, with or without
hydrocephalus13
Occasionally, frank LM are not seen on MRI,
but bulky subependymal disease or multiple
small sulcal metastases suggest the diagnosis13
13-Pathophysiology, clinical features, and diagnosis of leptomeningeal metastases (carcinomatous meningitis), Uptodate
36. In patients with encephalopathy and no
localizing findings on MRI, the diagnosis
may be suggested by positron emission
tomography (PET) demonstrating diffusely
diminished glucose utilization in an
otherwise normal-appearing brain13
13-Pathophysiology, clinical features, and diagnosis of leptomeningeal metastases (carcinomatous meningitis), Uptodate
37.
38. MRI can show linear enhancement of
the entire cord and linear or nodular
enhancement of the cauda equina.13
Occasionally, clumping of nerve roots at
the cauda equina suggests the diagnosis
if contrast enhancement is not seen.13
A spinal tumor may obstruct CSF flow,
resulting in hydrocephalus
13-Pathophysiology, clinical features, and diagnosis of leptomeningeal metastases (carcinomatous meningitis), Uptodate
39.
40.
41.
42. CSF analysis is the gold standard for diagnosis of LM.12
The presence of malignant cells in the CSF is
diagnostic of LM. (sensitivite 71% → 86% → 93% →…)12
The CSF is abnormal in nearly all patients, but many
abnormalities are non-specific.11
Abnormalities include11
1. increased opening pressure (200 mm of H2O)
2. Increased leukocytes (4/mm3)
3. elevated protein (50 mg/dL)
4. decreased glucose (60 mg/dL)
› which, though suggestive of LM, are not diagnostic.
11-Roelein h., Leptomeningeal metastases, Cancer treatment and research, Springer 2005
12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):328–342.
44. 12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
45.
46.
47. Tumor markers (eg, CEA, PSA, CA-15-3, CA-125, and
MART-1 and MAGE-3 in melanoma) may provide
evidence for CSF dissemination of disease, even when
serial cytological evaluations are negative.13
Level of tumor markers are compared between CSF
and Serum if CSF level greater than 1% of that in the
serum is virtually diagnostic of LM.12
12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
13-Pathophysiology, clinical features, and diagnosis of leptomeningeal metastases (carcinomatous meningitis), Uptodate
48.
49. Use of monoclonal antibodies for
immunohistochemical analysis in LM does not
significantly increase the sensitivity of cytology
alone.
However, in the case of leukemia and lymphoma,
antibodies against surface markers can be used to
distinguish between reactive and neoplastic
lymphocytes in the CSF.
50. Cytogenetic studies have also been evaluated in an
attempt to improve the diagnostic accuracy of LM.
Flow cytometry and DNA single cell cytometry,
techniques that measure the chromosomal content
of cells, and fluorescent in situ hybridization (FISH) that
detects numerical and structural genetic aberrations
as a sign of malignancy can give additional
diagnostic information but still have a low sensitivity.
In cases where there is no manifestation of systemic
cancer and CSF examinations remain inconclusive,
a meningeal biopsy may be diagnostic.
52. The evaluation of treatment of LM is complicated by
the lack of standard treatments
The difficulty of determining response to treatment
given the suboptimal sensitivity of the diagnostic
procedures and that most patients will die of
systemic disease, and the fact that most studies are
small, nonrandomized,and retrospective
However, it is clear that treatment of LM can
provide effective palliation and in some cases result
in prolonged survival.
Treatment requires the combination of surgery,
radiation, and chemotherapy in most cases
53. Goals of treatment
› The goals of treatment include stabilizing or
improving neurologic function, prolonging
survival and if these are not possible
Prognosis
› depending upon the tumor type and extent
of both neurologic and systemic disease
Patient
› Good risk vs Poor risk patient
54.
55.
56. The palliative regimen can include the
following components:
› RT can be useful for relief of symptoms caused
by localized leptomeningeal metastases.
› Analgesics are given for persistent pain.
› Anticonvulsants should be reserved for patients
with seizures (10 to 20 percent of cases) and
should not be administered prophylactically.
› Serotonin reuptake inhibitors or stimulant
medications (eg, modafinil, methylphenidate)
may be beneficial for patients with significant
depression or fatigue.
57. Treatment is directed at controlling the
tumor.
RT is used to treat bulky or symptomatic
areas of leptomeningeal disease,
intrathecal (IT) or systemic
chemotherapy is given to achieve
therapeutic concentrations in the CSF
59. Use in treatment of LM for the placement of
1. Intraventricular catheter and subgaleal
reservoir for administration of cytotoxic drugs
2. Ventriculoperitoneal shunt in pts with
symptomatic hydrocephalus
Drugs can be instilled into the subarachnoid
space by lumbar puncture or via an
intraventricular reservior system
60. 2 basic types of reseviors
1. Rickham reservior : a flat rigid reservior placed
over a burr hole
2. Ommaya resevior : a dome-shaped resevior
Reserviors are generally placed over
nondominant frontal region, catheter is
placed into frontal horn of the lateral
ventricle or close to the foramen of Monro.
Correct placement of the catheter by
noncontrast CT prior to its use for drug
administration, and frequently it will show a
small amount of air in both frontal horns.
61.
62. Used in treatment of LM for
1. Palliation of symptoms, such as a cauda equina
syndrome.
2. To decrease bulky disease such as coexistent
parenchymal brain metastases.
3. To correct CSF flow abnormalities demonstrated
by radionuclide ventriculography.
12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
63. RT appears to be more effective at relieving
symptoms than does IT chemotherapy.
Standard treatment for LM includes
palliative RT (30 to 36 Gy in 3 Gy daily
fractions) to sites of symptomatic or bulky
disease.
Suggest administering RT to sites of
obstruction of CSF flow, as demonstrated by
a radionuclide CSF flow study, prior to IT
chemotherapy.
12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
64. To avoid excess myelosuppression and other
toxicity such as severe fatigue, esophagitis,
diarrhea, and nausea, focal rather than
craniospinal RT is preferred.
Radiation is usually targeted to symptomatic
areas even in the absence of MRI
abnormalities:
› Cranial irradiation is used in patients with isolated
cranial neuropathies or focal collections of
malignant cells causing noncommunicating
hydrocephalus.
› Patients with lower extremity weakness, or bladder or
bowel dysfunction, generally receive lumbosacral
spine irradiation.
12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
65. Chemotherapy is the only treatment
modality that can treat the entire
neuraxis.
Systemic VS Intrathecal CMT
12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
66. Systemic chemotherapy is limited by
› Penetration of drug into the CNS
› Degree of chemoresistance of primary tumor
High doses of Methotrexate (3 – 8 g/m2) or
cytarabine (3 g/m2) produce high enough
serum levels to allow for therapeutic levels
in CSF, but very low permeability.
Capecitebine, thiotepa and temozolomide
cross BBB more effectively and potent for
treatment LM.
12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
67. Systemic chemotherary use in pt with
concomitant parenchymal, dural or
systemic metastasis.
Choice of agent depend on
› Tumor histology
› Prior drug exposure
12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
68. IT CMT is the mainstay of treatment for LM.
IT chemotherapy infuse directly into the
subarachnoid space via
› Lumbar puncture
› Intraventricular reservoir (Ommaya)
Methotrexate, thiopeta, cytarabine or
sustained-release cytarabine can be used.
Minimizes systemic S/E and eliminate BBB or
blood-CSF barrier drug penetration.
12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
69. 12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
70.
71. Most common toxicity is an acute
aseptic meningitis, occuring 2-4 hr after
drug instillation.
› Corticosteroids can be used to prevent or
treat
IT injection via LP can result in
inadvertent subdural or epidural drug
delivery.
12-Jennifer L. Clarke, Leptomeningeal Metastasis From Systemic Cancer, Continuum Lifelong Learning Neurol 2012;18(2):32–342.
74. LM often causes communicating
hydrocephalus → ↑ ICP
Elevated ICP is treated initially with
dexamethasone, and a dose of 8 mg twice
a day is usually effective.
› Dexamethasone should be started early and the
dose reduced as quickly as possible until the
lowest effective dose is achieved.
Dexamethasone → RT →
Ventriculoperitoneal shunting → Reservoir +
IT CMT
75. Diagnosis
Supportive care Treatment
Poor prognosis Good Prognosis
CNS imaging
Bulking disease
or symptomatic
sites
No bulky diasease
Ommaya placement
Marc C.,Neuroplastic Meningitis, The Neurologist 2006:12 : 180
77. CSF flow study
CSF flow block Normal CSF flow
IT ChemotherapyRT to site of block
CSF flow study
CSF flow block Normal CSF flow
Marc C.,Neuroplastic Meningitis, The Neurologist 2006:12 : 180
79. A 40 year-old women presented with
progressive headache for 3 weeks. She
notices that the headache was aggrevated
by lying down or cough. The headache did
not respond to acetaminophen
She had breast cancer diagnosis 2 years
ago with positive axillary LNs.
She was treated with neoadjuvant
chemotherapy (doxorubicin and
cyclophosphamide), followed by docetaxel
and tratuzumab with complete cycles.
80. Her neurological examination showed
papilledema.
MRI brain demonstrated T1-weighted
gadolinium-enhanced of leptomeninges
coating along brainstem and cerebellar
folia.
CSF showed 10 WBC, protein of 82 mg/dL,
and glucose of 64 mg/dL.
Cytology demonstrated numerous
malignant cells.
81.
82.
83. A 60 year-old man presented with
progressive right facial palsy, followed by
bilateral lower extremities weakness and
urinary incontinence for 3 weeks. He also
had mid-thoracic back pain.
He has been diagnosed with stage IIIA non-
small cell lung cancer with metastasis to
ipsilateral mediastinal LNs.
He was treated with cisplatin and
etoposide followed by surgery 1 year ago.
84. Neurological examination revealed right
facial palsy (UMN), bilateral legs weakness
(gr III), more severe on left side, with
decreased reflex on right knee jerk and left
ankle jerk.
MRI spine showed gadolinium enhancing
lesion along cauda equine.
CSF showed 15 WBC, protein 72 mg/dL and
glucose 20 mg/dL.
Cytology showed malignant cells.
85. A. brain abscess
B. leptomeningeal carcinomatosis
C. paraneoplastic cerebellar degeneration
D. pseudotumor cerebri
E. viral meningitis
86. A. breast cancer
B. lung cancer
C.melanoma
D. prostate cancer
E. thyroid cancer